Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.
In Lewy body diseases and multiple system atrophy, alpha-synuclein is hyperphosphorylated at Ser129, suggesting a role in pathogenesis. Here, we report purification of the protein kinase in rat brain that phosphorylates Ser129 and its identification as casein kinase-2 (CK2). We show that most of the activity can be inhibited by heparin, an inhibitor of CK2. Phosphorylated Ser129 was detected in primary cultured neurons and inhibited by CK2 inhibitors. In some cases of Lewy body disease, CK2-like immunoreactivity was recovered in the sarkosyl-insoluble fraction, which was enriched in phosphorylated alpha-synuclein. Taken together, these findings suggest that CK2 may be involved in the hyperphosphorylation of alpha-synuclein in alpha-synucleinopathies.
Ishii
Aasami
A
Department of Molecular Neurobiology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan.
Nonaka
Takashi
T
Taniguchi
Sayuri
S
Saito
Taro
T
Arai
Tetsuaki
T
Mann
David
D
Iwatsubo
Takeshi
T
Hisanaga
Shin-Ichi
S
Goedert
Michel
M
Hasegawa
Masato
M
D000409:Alanine / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D047390:Casein Kinase II / Q000378:metabolism*; D000939:Epitopes / Q000276:immunology; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D009154:Mutation / Q000235:genetics; D019636:Neurodegenerative Diseases / Q000235:genetics / Q000378:metabolism*; D010768:Phosphoserine / Q000378:metabolism*; D051381:Rats; D046509:Tissue Culture Techniques; D051844:alpha-Synuclein / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
D000939:Epitopes; D051844:alpha-Synuclein; D010768:Phosphoserine; D006493:Heparin; D047390:Casein Kinase II; D000409:Alanine